A detailed history of Davenport & CO LLC transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Davenport & CO LLC holds 56,897 shares of BIO stock, worth $18.9 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
56,897
Previous 56,307 1.05%
Holding current value
$18.9 Million
Previous $15.4 Million 23.79%
% of portfolio
0.11%
Previous 0.1%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$263.97 - $344.64 $155,742 - $203,337
590 Added 1.05%
56,897 $19 Million
Q2 2024

Aug 06, 2024

BUY
$268.26 - $339.48 $3.21 Million - $4.06 Million
11,954 Added 26.95%
56,307 $15.4 Million
Q1 2024

May 03, 2024

BUY
$304.11 - $351.99 $13.5 Million - $15.6 Million
44,353 New
44,353 $15.3 Million
Q1 2022

May 02, 2022

SELL
$524.57 - $735.42 $151,076 - $211,800
-288 Closed
0 $0
Q3 2021

Oct 14, 2021

BUY
$657.71 - $825.77 $189,420 - $237,821
288 New
288 $215,000

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.2B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Davenport & CO LLC Portfolio

Follow Davenport & CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Davenport & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Davenport & CO LLC with notifications on news.